Microarray Analysis Market Research Report- Forecast To 2030

Microarray Analysis Market Insights and Trends By Types (DNA Microarray, Protein Microarray), Application (Research, Genotyping, Forensic), Product Type (Reagent, Primers, Buffer), End-User (Pharmaceuticals, Biotechnology)-Forecast Till 2030

ID: MRFR/LS/0394-HCR | January 2023 | Region: Global | 115 Pages         

Microarray Analysis Market Speak to Analyst Request a Free Sample

Microarray Analysis Market

Microarray Analysis Market for this is expected to reach USD 4649.01 Million by the end of the forecast period growing at a CAGR of 6.90%.

Segmentation
By Types DNA Microarray Protein Microarray
Application Research Genotyping Forensic
Product Type Reagent Primers Buffer
End-User Pharmaceuticals Biotechnology
Key Players
Companies Profiled   Affymetrix    Inc.    Agilent Technologies    Inc.    Sequenom    Inc.    Roche NimbleGen    Illumnia    Inc.    and Applied Microarrays. Other companies operating in the global microarrays market are biomerieux SA    Discerna    Gyros AB    Luminex Corporation    NextGen Sciences    PLC    Thermo Fisher Scientific    and ProteoGenix.
Drivers
Market Driving Forces   The Rising Focus on drug discovery    personalized medicines    and targeted therapy are driving the growth of the market   Rising Prevalence of cancer and increasing investments for cancer research can drive the market growth.
Request a Free Sample

Microarray Analysis Market Scenario


The Microarray Analysis Market is expected to reach USD 4649.01 Million by 2030 at 6.90% CAGR during the forecast period 2022-2030. The microarray analysis market is expected to witness tremendous growth during the forecast period. Microarray analysis is a molecular biology technique that uses microchips containing attached short DNA segments which are used for the analysis of gene expression on a large scale. This enables medical practitioners to decide the most effective treatment for individual patients. Microarray analysis can be used in various experiments such as epigenetics, genotyping, biomarker profiling, translation profiling, pathway identification mutations, and gene expression profiling. The techniques allow the scientists to analyze several genes at a time with accurate results. The rising prevalence of genetic disorders, increased focus on drug discovery and development, and rising demand for personalized medicines are driving the market growth.  According to the Genetic Disorders UK 2017, every year approximately 30,000 new born children are diagnosed with genetic diseases. Microarray analysis helps in understanding the gene patterns in different types of tumors. They are also used for detection of cancer biomarker and also for its research. Hence the rising prevalence of cancer and increasing investments for cancer research can drive the market growth.


However, factors such as high costs of diagnosis, contamination, and inaccurate results are expected to hinder the market growth during the forecast period 


Segmentation


The global microarray analysis market is segmented on the basis of type, application, product type, and end-user.  The global microarray analysis market, by type, is segmented into DNA microarrays, protein microarrays, tissue microarrays, cellular microarrays, chemical compound microarrays, glycan arrays, and phenotype microarrays. The application segment is segmented into research, genotyping, forensic analysis, proteomics, genomics, disease diagnosis, drug discovery, and toxicological research. The product type segment is further sub-segmented into reagents, primers, buffers, DNA chips, reagent kits, and instruments. The instrument category consists of scanner, hybridization oven, Multi-Channel (MC) instrument, target preparation instrument, slide imprinters, centrifuge, and others. On the basis of end-user, the market is categorized into pharmaceuticals, biotechnology, hospitals and clinics, diagnostic centers, academic and research institutes, and ambulatory care centers.


On the basis of region, the global microarray analysis market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.


The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Key players


Some of the key players for the global microarray analysis market are Affymetrix, Inc., Agilent Technologies, Inc., Sequenom, Inc., Roche NimbleGen, Illumnia, Inc., and Applied Microarrays. Other companies operating in the global microarrays market are biomerieux SA, Discerna, Gyros AB, Luminex Corporation, NextGen Sciences, PLC, Thermo Fisher Scientific, and ProteoGenix.


Regional Market Summary


Global Microarray Analysis Market Share (%), by Region, 2017


Microarray Analysis Market Share


Sources: National Cancer Institute, World Health Organization, European Commission, ALZHEIMER'S DISEASE INTERNATIONAL


The microarray analysis market is dominated by the Americas owing to the adoption of advanced technology for diagnosis, awareness among people for better diagnostics, and high investments in research. The National Cancer Institute received USD 5.665 billion from the States Congress for cancer research programs in 2018.


It is estimated that Europe was the second largest in the global microarray analysis market.  The rising focus on drug discovery, personalized medicines, and targeted therapy are driving the growth of the market in this region. In November 2016, over 30 European and international members along with the European Commission established an initiative called the International Consortium for Personalized Medicine, or "ICPerMed" to establish Europe as a global leader in personalized medicine research. Thus, the increasing research in personalized medicines serves favorable backgrounds for the market to grow in this region.


The microarray analysis market in Asia-Pacific is expected to witness growth owing to rising prevalence of genetic disorders, growing awareness among the people, and government initiatives.  According to Alzheimer's Disease International, in 2015, 23 million people in the Asia-Pacific region had dementia, and by 2050 the number is expected to rise to 71 million.


The Middle East and Africa holds the least share in the global microarray analysis market due to low funding in medical and health research. However, the rising prevalence of genetic diseases and increasing healthcare spending favor the market growth in this region.


Intended Audience



  • Hospitals

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers


Market Segmentation and Key Market Players



  • Affymetrix, Inc.

  • Agilent Technologies, Inc.

  • Sequenom, Inc

  • Roche NimbleGen

  • Illumina, Inc

  • Applied Microarrays

  • Biomerieux SA,

  • Discerna,

  • Gyros AB,

  • Luminex Corporation,

  • NextGen Sciences, PLC.,

  • Thermo Fisher Scientific

  • ProteoGenix


Global Microarray Analysis Market, by Type



  • DNA microarrays

  • Protein microarrays

  • Tissue microarrays

  • Cellular microarrays

  • Chemical compound microarrays

  • Antibody microarrays

  • Glycan arrays

  • Phenotype microarrays


Global Microarray Analysis Market, by Application 



  • Research

  • Genotyping

  • Forensic Analysis

  • Proteomics

  • Genomics

  • Disease Diagnosis

  • Drug Discovery

  • Toxicological Research


Global Microarray Analysis Market, by Product Type



  • Reagents

  • Primers

  • Buffers

  • DNA chips

  • Reagent kits


  • Instruments

    • Scanner

    • Hybridization Oven

    • Multi-Channel (MC) Instrument

    • Target Preparation Instrument

    • Slide Imprinters

    • Centrifuge




Global Microarray Analysis Market, by End-User



  • Pharmaceuticals

  • Biotechnology

  • Hospitals & Clinics

  • Ambulatory Care Centers

  • Diagnostic Centers

  • Academic and Research Institutes


Global Microarray Analysis Market, by Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 4649.01 Million
  CAGR   6.90%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Application, Product Type, End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Affymetrix, Inc., Agilent Technologies, Inc., Sequenom, Inc., Roche NimbleGen, Illumnia, Inc., and Applied Microarrays. Other companies operating in the global microarrays market are biomerieux SA, Discerna, Gyros AB, Luminex Corporation, NextGen Sciences, PLC, Thermo Fisher Scientific, and ProteoGenix.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • The Rising Focus on drug discovery, personalized medicines, and targeted therapy are driving the growth of the market.
  • the Rising Prevalence of cancer and increasing investments for cancer research can drive the market growth.


  • Speak to Analyst Ask for Customization